The group AGEL has posted a growth in its consolidated business result before taxation by 17% y/y to CZK 740.8m for the year 2015. According to Ján Dudra, the chairman of the board of directors of AGEL, the group will reinvest over CZK 500m from its profits to its hospitals in 2016. More investments will head to science and research projects, clinic studies, and education events and projects. In 2015, hospitals AGEL hospitalised 170,000 patients in 2015. The hospitals registered also 2.5 million outpatient treatment procedures.